The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation.
about
Integrating psychotherapy and pharmacotherapy in the treatment of premature ejaculationThe office management of ejaculatory disordersThe drug treatment of premature ejaculationEmerging and investigational drugs for premature ejaculationThe characterization, current medications, and promising therapeutics targets for premature ejaculationAdvances in treating premature ejaculation.An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE).New insights on premature ejaculation: a review of definition, classification, prevalence and treatmentClinical correlates of enlarged prostate size in subjects with sexual dysfunctionAnatomy of sex: Revision of the new anatomical terms used for the clitoris and the female orgasm by sexologists.An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors.Tramadol for the management of premature ejaculation: a timely systematic review.Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): How do they work?Erectile dysfunction and its management in patients with diabetes mellitus.Advances in understanding and treating premature ejaculation.Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis.Premature ejaculation: do we have effective therapy?Pelvic floor muscle rehabilitation for patients with lifelong premature ejaculation: a novel therapeutic approach.Efficacy of combined traditional Chinese medicine spray with premature ejaculation desensitization therapy for the treatment of primary premature ejaculation.Seminal vesicles and diabetic neuropathy: ultrasound evaluation after prolonged treatment with a selective phosphodiesterase-5 inhibitor.Impact of erectile function and age in men with lower urinary tract symptoms on ejaculatory dysfunction and premature ejaculation.Prescribing of phosphodiesterase-5 inhibitors among psychiatrists.
P2860
Q26865863-18D260E0-4ECE-44C6-8D5C-CC468FABCD04Q28066740-7B387734-7296-4A1E-BE17-6177111BF031Q28072609-C98FD354-CD7F-4FB8-A2B5-A4C4F3CB24D6Q28078002-25AA3E5D-F390-46A3-B569-C22DCF5CB1E1Q28081739-D8127DC0-4DB4-4AE3-B69E-B35622646A70Q33942072-4722E6D9-C35D-4A8E-91E4-8A556EEC834AQ34286787-ED8F4ADF-8C50-4E73-8A08-C4346631BD9BQ34306031-EA4F0880-C1B7-4A47-A17A-21BA250EB91CQ34433316-A6F62A75-9885-4A9C-BA4D-B83A1E210D57Q34441825-4F2808B9-5702-4C02-AAF0-C525F41539B7Q38107001-2E74D8C6-DF41-4E83-A5DF-F562D18AEC0DQ38478249-3C83E9AD-BF58-475E-895D-9C37E952668BQ38542767-847765E2-074F-4D4D-B049-F158C139C04BQ38615555-7D3970E2-0F94-45B1-A27A-857889D25672Q38616683-618EC5A6-7247-4BF9-B134-8D3B3132071AQ38673414-50B4CD86-57ED-4E54-91FD-597F84BD7DBFQ38713715-9F0DE6EC-1894-49FE-95F1-40865DC4E964Q39037336-FF24B867-A897-4AD5-86CD-92D907AB4516Q44528653-07DC28F7-D1A6-4E43-89DB-A5ABACF5D8C8Q44868031-7922AD8E-5F2B-480A-BB22-62C2C569078CQ53134999-80186A30-736C-48A4-88C6-89046BC17C15Q54485888-8C57F970-F0B8-441D-B0DF-BB5D95BE4762
P2860
The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The controversial role of phos ...... ment of premature ejaculation.
@en
The controversial role of phos ...... ment of premature ejaculation.
@nl
type
label
The controversial role of phos ...... ment of premature ejaculation.
@en
The controversial role of phos ...... ment of premature ejaculation.
@nl
prefLabel
The controversial role of phos ...... ment of premature ejaculation.
@en
The controversial role of phos ...... ment of premature ejaculation.
@nl
P2093
P1476
The controversial role of phos ...... ment of premature ejaculation.
@en
P2093
Chris McMahon
Michael Perelman
P304
P356
10.1111/J.1743-6109.2011.02401.X
P577
2011-08-01T00:00:00Z